• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE INTEGRITY RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE INTEGRITY RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Device Problems Infusion or Flow Problem (2964); Material Deformation (2976)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/26/2019
Event Type  malfunction  
Manufacturer Narrative
Journal article: "clinical impact of the gap-angle ratio in patients with ostial lesions of the right coronary artery undergoing percutaneous coronary intervention" journal: heart and vessels year: 2019 ref: https://doi.Org/10.1007/s00380-019-01417.There is no established or suspected causal relationship between the device and the death events.Deaths are common occurrences in clinical studies, however the cause(s) of death are often not characterized or clearly associated with a particular product.Therefore, deaths will not be considered reportable unless clearly stated as being associated with a medtronic device.Age: average age, sex: majority gender, date of event: date of publication.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Resolute onyx rx zotarolimus eluting stents were among a number of des stents implanted in the study population as part of a study investigating the incidence of binary restenosis and its predictors in patients with ostial lesions of the coronary artery (rcaos) who underwent percutaneous coronary intervention (pci).Lesions treated included the femoral, brachial, radial, funnel-shaped ostium and de novo.Clinical outcomes of the procedures include cardiac death, myocardial infarction (mi), target lesion revascularisation (tlr), stent edge dissection.Malfunctions included stent under expansion and stent protrusion.
 
Manufacturer Narrative
None of the death events or adverse events that were mentioned within the article related directly to medtronic devices/products.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESOLUTE INTEGRITY RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key9451777
MDR Text Key175702183
Report Number9612164-2019-05112
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P110013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/11/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/05/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age72 YR
-
-